Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 1;13(1):172-175.
doi: 10.21037/hbsn-23-621. Epub 2024 Jan 16.

Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives

Affiliations
Editorial

Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives

Francesca Saffioti et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: American Association for the Study of Liver Diseases (AASLD); biliary cancer; guidelines; liver cancer; primary sclerosing cholangitis (PSC).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-621/coif). The authors have no conflicts of interest to declare.

Comment on

  • Hepatology. 77:659.

References

    1. Bowlus CL, Arrivé L, Bergquist A, et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023;77:659-702. 10.1002/hep.32771 - DOI - PubMed
    1. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660-78. 10.1002/hep.23294 - DOI - PubMed
    1. Ponsioen CY, Assis DN, Boberg KM, et al. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 2021;161:1764-1775.e5. 10.1053/j.gastro.2021.07.046 - DOI - PubMed
    1. European Association for the Study of the Liver . EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol 2022;77:761-806. Erratum in: J Hepatol 2023;79:1339.10.1016/j.jhep.2022.05.011 - DOI - PubMed
    1. Ponsioen CY, Lindor KD, Mehta R, et al. Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis. Hepatology 2018;68:1174-88. 10.1002/hep.29882 - DOI - PubMed

Publication types